GET THE APP

Antibodies and its Comparative Immune Responses in Humans
..

Immunochemistry & Immunopathology

ISSN: 2469-9756

Open Access

Short Communication - (2022) Volume 8, Issue 6

Antibodies and its Comparative Immune Responses in Humans

Haruki Murakami*
*Correspondence: Haruki Murakami, Department of Medicinal Chemistry, University of Illinois, Chicago, USA, Email:
Department of Medicinal Chemistry, University of Illinois, Chicago, USA

Received: 01-Dec-2022, Manuscript No. Icoa-23-96005; Editor assigned: 03-Dec-2022, Pre QC No. P-96005; Reviewed: 17-Dec-2022, QC No. Q-96005; Revised: 23-Dec-2022, Manuscript No. R-96005; Published: 30-Dec-2022 , DOI: 10.37421/2469-9756.2022.8.159
Citation: Murakami, Haruki. “Antibodies and its Comparative Immune Responses in Humans.” Immunochem Immunopathol 8 (2022): 159.
Copyright: © 2023 Murakami H. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Introduction

Antibodies, also known as immunoglobulin, are specialized proteins produced by the immune system in response to the presence of foreign substances called antigens. They play a critical role in the body's defence against pathogens, such as bacteria, viruses and other harmful substances. However, antibodies are proteins that are produced by specialized cells in the immune system of living organisms, including humans and are typically found within the blood and other bodily fluids. Antibodies are designed to recognize and neutralize foreign substances, such as pathogens like bacteria or viruses, in order to help the immune system fight off infections.

Description

Once produced, antibodies can travel throughout the body via the bloodstream to target specific antigens, which are the unique markers on the surface of pathogens that trigger an immune response. Antibodies can also be found in other locations within the body, such as in tissues and mucosal surfaces, depending on the specific immune response and the type of infection being targeted. Antibodies are highly specific, antibodies are designed to recognize and bind to specific antigens with high precision. This specificity allows them to target and neutralize specific pathogens, helping to prevent them from causing harm to the body. Antibodies come in different types, there are several different types of antibodies, including IgA, IgD, IgE, IgG and IgM, each with its own unique functions and roles in the immune response. For example, IgA is found in mucosal secretions and helps protect the mucous membranes, while IgG is the most common type of antibody in the blood and is involved in long-term immunity [1].

Antibodies can be produced by B cells: B cells, a type of white blood cell, are responsible for producing antibodies. When B cells encounter an antigen, they can differentiate into plasma cells, which produce and release large amounts of antibodies into the bloodstream. Antibodies have various functions: Antibodies can neutralize pathogens by binding to them and preventing them from entering or damaging host cells. They can also mark pathogens for destruction by other immune cells, such as phagocytes, which engulf and destroy the marked pathogens. Additionally, antibodies can activate other components of the immune system, such as the complement system, to enhance the immune response. Antibodies can be acquired through vaccination. Vaccines are a way to stimulate the immune system to produce specific antibodies against a particular antigen without causing the disease.

This helps the body build immunity to the pathogen, making it more effective at fighting off future infections. Antibodies can be used in medical treatments; antibodies can also be used in medical treatments, such as monoclonal antibody therapy. Monoclonal antibodies are engineered in the lab and can be designed to target specific antigens, such as those found on cancer cells or in autoimmune diseases, to help treat these conditions [2]. Antibodies are capable of recognizing specific pathogens or foreign substances, known as antigens that enter the body. Each antibody is designed to bind to a specific antigen, like a lock and key. This recognition helps the immune system to identify and distinguish between harmful substances and the body's own cells. Once antibodies bind to antigens, they can prevent the pathogens from infecting host cells. Antibodies can neutralize pathogens by blocking their entry into cells, preventing them from spreading and causing damage. Activation of immune response: Antibodies can also stimulate other immune cells to destroy pathogens. When antibodies bind to antigens on pathogens, they can trigger the activation of immune cells, such as macrophages and natural killer cells, to attack and destroy the pathogens [3].

Antibodies can enhance the process of phagocytosis, which is the engulfment and destruction of pathogens by immune cells. Antibodies can coat pathogens, making it easier for phagocytic cells to recognize and engulf them, leading to their destruction. Assistance in immune memory: Antibodies are also involved in the formation of immune memory. After an initial encounter with a pathogen, antibodies produced in response to that pathogen can persist in the body for a period of time, providing immunity and protection against future infections by the same pathogen antibodies play a critical role in the immune response by recognizing, neutralizing and helping to eliminate harmful pathogens, as well as assisting in the formation of immune memory. They are essential components of the body's defence against infections and are used in various medical applications, such as vaccines and immunotherapies [4,5].

Conclusion

In conclusion, antibodies are critical components of the immune system that play a crucial role in defending the body against pathogens. Their specificity, diversity and various functions make them an essential part of the body's immune response and important tools in medical treatments and vaccinations.

Acknowledgement

None.

Conflict of Interest

The author shows no conflict of interest towards this article.

References

  1. Fernández-Hidalgo, Núria, Laura Escolà-Vergé and Juan M. Pericàs. "Enterococcus faecalis endocarditis: What’s next?."Future Microbiol 15 (2020): 349-364.
  2. Google Scholar, Crossref, Indexed at

  3. Benes, Jiri, Olga Dzupova, Marek Setina and Rudolf Feuereisl, et al. "Relapsing endocarditis caused by Enterococcus faecalis forming small colony variants."Scand J Infect Dis 45 (2013): 800-803.
  4. Google Scholar, Crossref, Indexed at

  5. Egido, S. Hernández, M. Siller Ruiz, S. Inés Revuelta and I. García García, et al. "Enterococcus faecium small colony variant endocarditis in an immunocompetent patient."New Microbes New Infect 9 (2016): 47-49.
  6. Google Scholar, Crossref, Indexed at

  7. Wellinghausen, Nele, Indranil Chatterjee, Anja Berger and Andrea Niederfuehr, et al. "Characterization of clinical Enterococcus faecalis small-colony variants."J Clin Microbiol47 (2009): 2802-2811.
  8. Google Scholar, Crossref, Indexed at

  9. Royer, G., E. Melloul, L. Roisin and V. Courbin, et al. "Complete genome sequencing of Enterococcus faecalis strains suggests role of ebp deletion in infective endocarditis relapse."Clin Microbiol Infect 25 (2019): 1565-1567.
  10. Google Scholar, Crossref, Indexed at

arrow_upward arrow_upward